Quoin Pharmaceuticals Ltd.

QNRX Nasdaq SEC CIK 1671502
Follow Quoin Pharmaceuticals Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$4.9M −23.4% vs same quarter last year
EPS, diluted -
Operating cash flow −$5.8M −159.3% vs same quarter last year
Net income by quarter
−$2.3M
−$3.8M
−$3.7M
−$3.9M
−$4.3M
−$5M
−$5.4M
−$4.9M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$30M−$20M−$10M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25-−$15.8M
FY24-−$9M
FY23-−$8.7M
FY22-−$9.4M
FY21$0−$21.5M
FY20$0−$2.1M
FY19$0−$1.6M
FY18--